Search

everythinglearnresearchcommunity

for

Search:↓

The skin's immune system helps it regenerate and fight infections.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Immune cells help keep skin healthy and repair it, but imbalance can cause disease.

Diet may help manage hidradenitis suppurativa symptoms.

Thyroid disorders are linked to skin conditions like vitiligo and hair loss, so thyroid tests are recommended.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

Current treatments for alopecia areata can help hair grow but don't cure the disease.

Early intervention and patient education are crucial for managing alopecia areata.

Endocrine disorders can cause various skin and hair issues.

A thorough history and examination are crucial for diagnosing skin diseases, which affect up to a third of people. This includes details about skin lesions, medication, general health, lifestyle, family, and contacts, as well as examining the rash, hair, nails, and mucous membranes. Changes in hair and nails can also indicate other medical and skin disorders.

An integrated approach can help treat childhood alopecia areata.

Microneedle patches improve drug delivery for skin treatments and cosmetic enhancements.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

The document provides a method to classify human hair growth stages using a model with human scalp on mice, aiming to standardize hair research.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

The multi-injection plate is a less painful and more efficient method for treating patchy hair loss.

A woman developed white patches on her skin and curly hair after hepatitis C treatment, likely due to the medication interferon alpha.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Hair loss in Cronkhite-Canada syndrome may be due to an autoimmune response.